AI news impact · US stocks
Hims & Hers Health, Inc. Class A (HIMS) news impact
On 2026-11-11 Wave Radar's AI rated the news on Hims & Hers Health, Inc. Class A as major negative (impact score −75%).
FTC expanded its billing and privacy lawsuit against Hims & Hers with five states joining. The company also missed Q3 estimates, saw margin contraction, and cut 2026 adjusted EBITDA guidance.
- Direction
- Major negative
- Impact score
- −75%
- Confidence
- 90%
- Headlines read
- 5
- Flags
- Major risk
- Date
- 2026-11-11
AI assessment
Escalating regulatory litigation combined with weak earnings and lower profitability guidance create severe dual headwinds.
Sector impact
Telehealth and DTC pharmaceutical providers face heightened regulatory oversight and margin scrutiny.
Headlines the AI read
- Hims & Hers Climbs 6% Despite Five States Joining FTC Suit; Eli Lilly Dips, Novo Nordisk Holds Steady Yahoo Finance/HIMS · 2026-11-11
- FTC Widens Its Hims & Hers Suit as Five States Join Over Privacy and Billing Yahoo Finance/HIMS · 2026-11-11
- Hims & Hers Q3 Earnings Miss Estimates, Gross Margin Down Yahoo Finance/HIMS · 2026-11-11
- Hims & Hers Faces A ‘Transition Year’ Amid Increasing AI Investments, Says KeyBanc – Expects Lower Pricing To Weigh On FY2027-2028 Earnings Outlook Yahoo Finance/HIMS · 2026-11-11
- Hims & Hers Health Faces Expanded FTC Lawsuit Over Privacy, Billing Practices Yahoo Finance/HIMS · 2026-11-11
Rating history
One rating per trading day the stock was covered.
More on Hims & Hers Health, Inc. Class A
How the rating works
After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.